Vara introduces Autonomous Triage, a new category of breast AI
Its CE certificate allows the AI to report normal cases below a suspiciousness threshold without a radiologist, following earlier CADe, CADx and independent-reader milestones.
See the latest news and media coverage for Vara. We track all announcements, press releases, and industry mentions in real time, all in one place.
Medical artificial intelligence for breast cancer screening
vara.aiLast updated
In short: Vara became the world’s first to receive CE certification for autonomous AI breast-screening triage
Its CE certificate allows the AI to report normal cases below a suspiciousness threshold without a radiologist, following earlier CADe, CADx and independent-reader milestones.
Its Autonomous Triage reports clearly normal screening mammograms with no radiologist reading them, safeguarded by ATMON, which reverts a site to human reading when performance signals drift.
It is the only AI authorised as an independent second reader for screening and diagnostic use, marking Vara's entry into the European market.
The nationwide German study of 500,000 participants improved detection by 17.6% without more false positives and cut radiologist reading time 43%.
The autonomous triage system’s European market authorisation comes as AI becomes increasingly embedd...
Vara has received CE certification under the EU Medical Device Regulation (Class IIb) for autonomous triage in organised breast cancer screening - the first breast...
BERLIN, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Vara announced today it received a new CE certificate for its new breast-imaging AI – the only on...
– Vara, a Berlin, Germany-based provider of AI-enabled breast cancer detection, has announced the successful closure of a $8.9M (€8M EUR) Series B funding round...
Track Vara and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Vara and other trending companies.